Serodus ASA is a pharmaceutical company based in Oslo, which specializes in the development of treatments for patients with diabetic kidney disease. The company aims to postpone the need for dialysis, which can have a major impact on the quality of life of affected patients. To achieve this, Serodus ASA uses two different modes of action in its development process, which can contribute to a broader approach to the treatment of kidney disease.
The company attaches great importance to innovation in the treatment of kidney disease, and works continuously to explore new opportunities to improve existing therapies. In addition, Serodus ASA is considering potential acquisitions to strengthen its own pipeline, which can contribute to the further development of effective treatments. Through its focus on research and development, the company seeks to make a significant impact in the field of kidney disease treatment.